Authors:
Barlogie, B
Desikan, R
Eddlemon, P
Spencer, T
Zeldis, J
Munshi, N
Badros, A
Zangari, M
Anaissie, E
Epstein, J
Shaughnessy, J
Ayers, D
Spoon, D
Tricot, G
Citation: B. Barlogie et al., Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 studyof 169 patients, BLOOD, 98(2), 2001, pp. 492-494
Authors:
Skirvin, RM
Kohler, E
Steiner, H
Ayers, D
Laughnan, A
Norton, MA
Warmund, M
Citation: Rm. Skirvin et al., The use of genetically engineered bacteria to control frost on strawberries and potatoes. Whatever happened to all of that research?, SCI HORT A, 84(1-2), 2000, pp. 179-189
Authors:
Desikan, R
Barlogie, D
Sawyer, J
Ayers, D
Tricot, G
Badros, A
Zangari, M
Munshi, NC
Anaissle, E
Spoon, D
Siegel, D
Jagannath, S
Vesole, D
Epstein, J
Shaughnessy, J
Fassas, A
Lim, S
Roberson, P
Crowley, J
Citation: R. Desikan et al., Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities, BLOOD, 95(12), 2000, pp. 4008-4010
Authors:
Singhal, S
Mehta, J
Desikan, K
Siegel, D
Singh, J
Munshi, N
Spoon, D
Anaissie, E
Ayers, D
Barlogie, B
Citation: S. Singhal et al., Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy, BONE MAR TR, 24(1), 1999, pp. 13-17
Authors:
Singhal, S
Mehta, J
Desikan, R
Ayers, D
Roberson, P
Eddlemon, P
Munshi, N
Anaissie, E
Wilson, C
Dhodapkar, M
Zeldis, J
Barlogie, B
Siegel, D
Crowley, J
Citation: S. Singhal et al., Antitumor activity of thalidomide in refractory multiple myeloma., N ENG J MED, 341(21), 1999, pp. 1565-1571
Authors:
Barlogie, B
Jagannath, S
Desikan, KR
Mattox, S
Vesole, D
Siegel, D
Tricot, G
Munshi, N
Fassas, A
Singhal, S
Mehta, J
Anaissie, E
Dhodapkar, D
Naucke, S
Cromer, J
Sawyer, J
Epstein, J
Spoon, D
Ayers, D
Cheson, B
Crowley, J
Citation: B. Barlogie et al., Total therapy with tandem transplants for newly diagnosed multiple myeloma, BLOOD, 93(1), 1999, pp. 55-65
Authors:
Gelmon, KA
Tolcher, A
O'Reilly, S
Campbell, C
Bryce, C
Shenkier, T
Ragaz, J
Ayers, D
Nakashima, L
Rielly, S
Dulude, H
Citation: Ka. Gelmon et al., A phase I-II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer, ANN ONCOL, 9(11), 1998, pp. 1247-1249